Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Dublin, Aug. 10, 2017 -- The "Pharma App Benchmarking 2017" report has been added to Research and Markets' offering.
Since the first report about the app publishing activities of leading Pharma companies was published in 2014, companies have intensified their activities in the digital health market. This report analyses the current status of the app publishing activities of the twelve leading Pharma companies globally. It also analyses newly established channels that Pharma use to partner with 3rd party companies, including accelerators/incubators, investment funds and direct partnerships.
The research provides a detailed perspective on the current status of digital health activities, on a market and company level. It compares the digital health activities that Pharma companies concentrate on, and how successful they are. The report also highlights how app publishing strategies have changed over the last three years.
Key Topics Covered:
1. Scope of the report
2. Management summary
3. The four channels used by Pharma to drive digital innovation with mHealth apps
4. The app publishing activities of top Pharma companies
5. Top 12 Pharma company app portfolio comparison
6. Top 12 Pharma company app profiles and digital health innovation activities
7. How can Pharma further evolve their digital health strategies?
8. Appendix
Companies Mentioned
- Abbott/Abbvie
- AstraZeneca
- Bayer Healthcare
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson&Johnson
- Merck
- Merck, Sharpe and Dohme (MSD)
- Novartis
- Pfizer
- Roche
- Sanofi
For more information about this report visit https://www.researchandmarkets.com/research/c28hjv/pharma_app
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals
